Caruba Thibaut, Brunie Vanida, Bousseau Véronique, Guillemain Romain, Prognon Patrice, Bégué Dominique, Sabatier Brigitte
Pharmacy Department, Hopital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.
Pharm World Sci. 2010 Jun;32(3):347-9. doi: 10.1007/s11096-010-9376-y. Epub 2010 Mar 10.
We report the case of a 12 year-old lung transplant recipient, in whom compressive epidural lipomatosis secondary to corticosteroid prompted us to replace prednisone with everolimus. Discontinuing corticosteroid treatment after lung transplantation is associated with a risk of graft rejection despite concomitant immunosuppressive therapy with tacrolimus and mycophenolate mofetil. During a follow-up of 18 months with everolimus instead of prednisone, we did not observe graft rejection. In parallel, all symptoms related to epidural compression disappeared within a month.
我们报告了一例12岁的肺移植受者病例,该患者因皮质类固醇导致压迫性硬膜外脂肪增多症,促使我们将泼尼松替换为依维莫司。尽管在肺移植后同时使用他克莫司和霉酚酸酯进行免疫抑制治疗,但停用皮质类固醇治疗仍与移植排斥反应风险相关。在使用依维莫司而非泼尼松进行18个月的随访期间,我们未观察到移植排斥反应。同时,与硬膜外压迫相关的所有症状在一个月内消失。